Breathe Well Live Well
Harvard School of Engineering and Applied Sciences |
Small airway-on-a-chip enables analysis of human COPD and asthma
News-Medical.net COPD and asthma are inflammatory reactions in the lung which can be dramatically exacerbated by viral and bacterial infections, as well as smoking. It is known that many of the associated disease processes occur in the conducting airway sections of the … Small airway-on-a-chip improves study of human COPD and asthma |
View full post on asthma – Google News
Harvard School of Engineering and Applied Sciences |
Small airway-on-a-chip improves study of human COPD and asthma
Harvard School of Engineering and Applied Sciences A research team at the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) and the Wyss Institute for Biologically Inspired Engineering at Harvard University leveraged its organ-on-a-chip technology to develop a model of the human … Modeling COPD and asthma in a human small airway-on-a-chip |
View full post on asthma – Google News
Medical Xpress |
Modeling COPD and asthma in a human small airway-on-a-chip
Medical Xpress COPD and asthma are inflammatory reactions in the lung which can be dramatically exacerbated by viral and bacterial infections, as well as smoking. It is known that many of the associated disease processes occur in the conducting airway sections of the … |
View full post on asthma – Google News
|
Modeling COPD and asthma in a human small airway-on-a-chip
EurekAlert (press release) COPD and asthma are inflammatory reactions in the lung which can be dramatically exacerbated by viral and bacterial infections, as well as smoking. It is known that many of the associated disease processes occur in the conducting airway sections of the … |
View full post on asthma – Google News
Condition: ASTHMA
Interventions: Genetic: asthma with proximal airways obstruction phenotype profile description with clinical, biological, morphologic and genetic elements.; Genetic: asthma with small airways dysfunction phenotype profile description with clinical, biological, morphologic and genetic elements.
Sponsor: Hospices Civils de Lyon
Not yet recruiting – verified October 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Monthly Prescribing Reference (registration) |
Prenatal Exposure to Acid Reducers: Small But Significant Asthma Risk
Monthly Prescribing Reference (registration) (HealthDay News) — Prenatal exposure to H2 blockers (H2Bs) or proton pump inhibitors (PPIs) is associated with a small but significantly increased risk of asthma in offspring, according to a study published online June 20 in the Journal of Clinical … |
View full post on asthma – Google News
|
Small Interfering RNA Against CD86 During Allergen Challenge Blocks …
Medscape Methods We investigated the effects of the downregulation of CD86 by short interfering RNAs (siRNAs) on Th2 cytokine production in the effector phase in vitro and on asthma phenotypes in ovalbumin (OVA)-sensitized and -challenged mice. |
View full post on asthma – Google News
Reuters |
AstraZeneca makes small front-end bet on potential asthma drug
Philly.com (blog) Having fended off Pfizer – for now, at least – AstraZeneca struck a much smaller deal to license a potential asthma drug being developed by Synairgen. AstraZeneca is based in the United Kingdom – London for now, but moving the headquarters to Cambridge … AstraZeneca builds pipeline with $232 million Synairgen asthma deal AstraZeneca licenses IFN-beta therapy for viral-induced asthma exacerbation AstraZeneca extends global shopping spree with $232M asthma drug deal |
View full post on asthma – Google News
|
VIDEO: Experimental inhaler targets small airways in asthma
The Oncology Report SAN DIEGO – An experimental inhalation system could help patients with asthma who are dependent on chronic oral corticosteroid therapy to reduce their doses of these steroids and potentially their side effects. A phase II/III study suggests the system … |
View full post on asthma – Google News
Condition: Asthma
Intervention:
Sponsor: Chiesi Farmaceutici S.p.A.
Not yet recruiting – verified April 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days